SAVARA INC's ticker is SVRA and the CUSIP is 805111101. A total of 76 filers reported holding SAVARA INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $102,658 | -49.2% | 52,645 | -65.9% | 0.00% | -60.0% |
| Q1 2022 | $202,000 | +5.8% | 154,263 | 0.0% | 0.01% | +25.0% |
| Q4 2021 | $191,000 | -10.3% | 154,263 | 0.0% | 0.00% | -33.3% |
| Q3 2021 | $213,000 | -42.4% | 154,263 | -29.1% | 0.01% | -50.0% |
| Q2 2021 | $370,000 | -11.7% | 217,560 | +8.1% | 0.01% | -25.0% |
| Q1 2021 | $419,000 | +46.5% | 201,309 | +75.1% | 0.02% | -20.0% |
| Q2 2020 | $286,000 | +286.5% | 115,000 | +311.7% | 0.02% | +185.7% |
| Q3 2019 | $74,000 | -32.7% | 27,931 | +132.8% | 0.01% | -46.2% |
| Q1 2018 | $110,000 | – | 12,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 3,313,602 | $12,525,416 | 47.59% |
| NEA Management Company, LLC | 24,471,264 | $92,501,378 | 7.14% |
| Bain Capital Life Sciences Investors, LLC | 14,232,751 | $53,799,799 | 6.02% |
| TCG Crossover Management, LLC | 10,000,000 | $37,800,000 | 5.57% |
| VR Adviser, LLC | 7,184,865 | $27,158,790 | 2.86% |
| Affinity Asset Advisors, LLC | 1,150,000 | $4,347,000 | 1.22% |
| Sio Capital Management, LLC | 896,250 | $3,387,825 | 1.05% |
| Frazier Life Sciences Management, L.P. | 4,000,000 | $15,120,000 | 1.00% |
| Vivo Capital, LLC | 1,913,349 | $7,232,459 | 0.79% |
| Nantahala Capital Management | 1,039,364 | $3,928,796 | 0.34% |